Brain biopsy in Creutzfeldt–Jakob disease: evolution of pathological changes by prion protein immunohistochemistry

The formation of protease‐resistant prion protein (PrPsc) is considered to be an early event in the pathogenesis of Creutzfeldt–Jakob disease (CJD) and hence its demonstration in brain biopsies by immunohistochemistry is considered diagnostic. We analysed eight brain biopsies from the frontal cortex collected from different parts of India from cases diagnosed as CJD on clinical and pathological grounds for the expression of prion protein (PrP). The duration of illness in these cases varied from 2 months to 1 year. Immunohistochemistry was carried out on paraffin sections using two different clones (KG9 and 3F4) of monoclonal antibodies to PrP. Although all eight cases showed classical features of spongiform encephalopathy of varying severity, only five of the eight cases revealed PrPsc in the brain tissue. The immunolabelling was focal and all areas with spongiform change were not labelled. A temporal evolution in the staining pattern was evident – particulate diffuse labelling (synaptic type) in early stages (2 months), perivacuolar deposits in intermediate stages (5–6 months), and dense plaques in late stages (12 months).

[1]  J. Martín,et al.  Retrospective study of Creutzfeldt-Jakob disease in Belgium: neuropathological findings , 2000, Acta Neuropathologica.

[2]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[3]  I. Whittle,et al.  Brain biopsy and patients with atypical presentations of sporadic Creutzfeldt- Jakob disease , 1997, Journal of Neurology Neurosurgery & Psychiatry.

[4]  P. Lantos,et al.  Prion protein immunocytochemistry – UK five centre consensus report , 1997, Neuropathology and applied neurobiology.

[5]  J. Ironside,et al.  Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt‐Jakob disease , 1996, Neuropathology and applied neurobiology.

[6]  J Q Trojanowski,et al.  Molecular basis of phenotypic variability in sporadc creudeldt‐jakob disease , 1996, Annals of neurology.

[7]  R. Castellani,et al.  Early pathologic and biochemical changes in Creutzfeldt-Jakob disease , 1996, Neurology.

[8]  K. Jellinger,et al.  Neuropathological Diagnostic Criteria for Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases) , 1995, Brain pathology.

[9]  R. Castellani,et al.  Regional distribution of protease‐resistant prion protein in fatal familial insomnia , 1995, Annals of neurology.

[10]  S. Prusiner,et al.  Etiology and pathogenesis of prion diseases. , 1995, The American journal of pathology.

[11]  M. Pocchiari,et al.  Detection of proteinase-resistant protein (PrP) in small brain tissue samples from Creutzfeldt-Jakob disease patients , 1994, Journal of the Neurological Sciences.

[12]  R. Shin,et al.  Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. , 1992, The American journal of pathology.

[13]  B. Crain,et al.  Evaluation of cerebral biopsies for the diagnosis of dementia. , 1992, Archives of neurology.

[14]  Jonathan O. Harris,et al.  Creutzfeldt‐Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering , 1979, Annals of neurology.